The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-Malarial Drug Market Research Report 2025
Synopsis
The global Anti-Malarial Drug market was valued at US$ 682.6 million in 2023 and is anticipated to reach US$ 818.1 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Malarial Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Malarial Drug.
Report Scope
The Anti-Malarial Drug market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Malarial Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Malarial Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer
Segment by Type
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Segment by Application
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Malarial Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Malarial Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Anti-Malarial Drug market was valued at US$ 682.6 million in 2023 and is anticipated to reach US$ 818.1 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Malarial Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Malarial Drug.
Report Scope
The Anti-Malarial Drug market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Malarial Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Malarial Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer
Segment by Type
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Segment by Application
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Malarial Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Malarial Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-Malarial Drug Market Overview
1.1 Product Overview and Scope of Anti-Malarial Drug
1.2 Anti-Malarial Drug Segment by Type
1.2.1 Global Anti-Malarial Drug Market Value Comparison by Type (2024-2030)
1.2.2 Plasmodium Falciparum
1.2.3 Plasmodium Vivax
1.2.4 Plasmodium Malariae
1.2.5 Plasmodium Ovale
1.3 Anti-Malarial Drug Segment by Application
1.3.1 Global Anti-Malarial Drug Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E-Commerce
1.3.5 Others
1.4 Global Anti-Malarial Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Malarial Drug Revenue 2019-2030
1.4.2 Global Anti-Malarial Drug Sales 2019-2030
1.4.3 Global Anti-Malarial Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Malarial Drug Market Competition by Manufacturers
2.1 Global Anti-Malarial Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Malarial Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Malarial Drug Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Malarial Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Malarial Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Malarial Drug, Product Type & Application
2.7 Anti-Malarial Drug Market Competitive Situation and Trends
2.7.1 Anti-Malarial Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Malarial Drug Players Market Share by Revenue
2.7.3 Global Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Malarial Drug Retrospective Market Scenario by Region
3.1 Global Anti-Malarial Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Malarial Drug Global Anti-Malarial Drug Sales by Region: 2019-2030
3.2.1 Global Anti-Malarial Drug Sales by Region: 2019-2024
3.2.2 Global Anti-Malarial Drug Sales by Region: 2025-2030
3.3 Global Anti-Malarial Drug Global Anti-Malarial Drug Revenue by Region: 2019-2030
3.3.1 Global Anti-Malarial Drug Revenue by Region: 2019-2024
3.3.2 Global Anti-Malarial Drug Revenue by Region: 2025-2030
3.4 North America Anti-Malarial Drug Market Facts & Figures by Country
3.4.1 North America Anti-Malarial Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Malarial Drug Sales by Country (2019-2030)
3.4.3 North America Anti-Malarial Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Malarial Drug Market Facts & Figures by Country
3.5.1 Europe Anti-Malarial Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Malarial Drug Sales by Country (2019-2030)
3.5.3 Europe Anti-Malarial Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Malarial Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Malarial Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Malarial Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Malarial Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Malarial Drug Market Facts & Figures by Country
3.7.1 Latin America Anti-Malarial Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Malarial Drug Sales by Country (2019-2030)
3.7.3 Latin America Anti-Malarial Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Malarial Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Malarial Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Malarial Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Malarial Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Malarial Drug Sales by Type (2019-2030)
4.1.1 Global Anti-Malarial Drug Sales by Type (2019-2024)
4.1.2 Global Anti-Malarial Drug Sales by Type (2025-2030)
4.1.3 Global Anti-Malarial Drug Sales Market Share by Type (2019-2030)
4.2 Global Anti-Malarial Drug Revenue by Type (2019-2030)
4.2.1 Global Anti-Malarial Drug Revenue by Type (2019-2024)
4.2.2 Global Anti-Malarial Drug Revenue by Type (2025-2030)
4.2.3 Global Anti-Malarial Drug Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Malarial Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Malarial Drug Sales by Application (2019-2030)
5.1.1 Global Anti-Malarial Drug Sales by Application (2019-2024)
5.1.2 Global Anti-Malarial Drug Sales by Application (2025-2030)
5.1.3 Global Anti-Malarial Drug Sales Market Share by Application (2019-2030)
5.2 Global Anti-Malarial Drug Revenue by Application (2019-2030)
5.2.1 Global Anti-Malarial Drug Revenue by Application (2019-2024)
5.2.2 Global Anti-Malarial Drug Revenue by Application (2025-2030)
5.2.3 Global Anti-Malarial Drug Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Malarial Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Anti-Malarial Drug Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Ranbaxy
6.2.1 Ranbaxy Corporation Information
6.2.2 Ranbaxy Description and Business Overview
6.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ranbaxy Anti-Malarial Drug Product Portfolio
6.2.5 Ranbaxy Recent Developments/Updates
6.3 Zydus Cadila
6.3.1 Zydus Cadila Corporation Information
6.3.2 Zydus Cadila Description and Business Overview
6.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zydus Cadila Anti-Malarial Drug Product Portfolio
6.3.5 Zydus Cadila Recent Developments/Updates
6.4 Alvizia
6.4.1 Alvizia Corporation Information
6.4.2 Alvizia Description and Business Overview
6.4.3 Alvizia Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Alvizia Anti-Malarial Drug Product Portfolio
6.4.5 Alvizia Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Anti-Malarial Drug Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Ipca
6.6.1 Ipca Corporation Information
6.6.2 Ipca Description and Business Overview
6.6.3 Ipca Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ipca Anti-Malarial Drug Product Portfolio
6.6.5 Ipca Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Anti-Malarial Drug Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 F. Hoffmann-La Roche
6.8.1 F. Hoffmann-La Roche Corporation Information
6.8.2 F. Hoffmann-La Roche Description and Business Overview
6.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolio
6.8.5 F. Hoffmann-La Roche Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novartis Anti-Malarial Drug Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Anti-Malarial Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Anti-Malarial Drug Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Malarial Drug Industry Chain Analysis
7.2 Anti-Malarial Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Malarial Drug Production Mode & Process
7.4 Anti-Malarial Drug Sales and Marketing
7.4.1 Anti-Malarial Drug Sales Channels
7.4.2 Anti-Malarial Drug Distributors
7.5 Anti-Malarial Drug Customers
8 Anti-Malarial Drug Market Dynamics
8.1 Anti-Malarial Drug Industry Trends
8.2 Anti-Malarial Drug Market Drivers
8.3 Anti-Malarial Drug Market Challenges
8.4 Anti-Malarial Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
